BRCA2 and invasive ductal breast carcinoma: First, we analyzed the mRNA levels of AURKB in prostate adenocarcinoma patients (46) and breast invasive ductal carcinoma patients (47) with low mRNA levels of BRCA2 from cBioPortal (48).